Vytorin Class Actions Now Total 85: Merck

By Amanda Ernst

Law360, New York (February 29, 2008, 12:00 AM ET) -- Merck & Co. Inc. has revealed that about 85 civil lawsuits have been filed against the company and its marketing partner Schering-Plough Corp. since mid-January, claiming the drugmakers broke state consumer protection laws through the sale and marketing of cholesterol-lowering drugs Vytorin and Zetia.

The revelation was made in Merck’s annual report, filed Thursday with the U.S. Securities and Exchange Commission. Before this announcement, the most recent tally had put the total number of proposed class actions filed against the drugmakers at just under 50....
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles